Jeena Sikho Lifecare Limited Stock Price Today (NSE: JSLL)
Fundamental Score
Jeena Sikho Lifecare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Jeena Sikho Lifecare Limited share price today is ₹590.60, up +19.99% on NSE/BSE as of 23 June 2026. Jeena Sikho Lifecare Limited (JSLL) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹8.96K (Cr). The 52-week high for JSLL share price is ₹849.50 and the 52-week low is ₹415.00. At a P/E ratio of 58.20x, JSLL is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 37.93% and a debt-to-equity ratio of 0.30.
Jeena Sikho Lifecare Limited Share Price Chart — NSE/BSE Historical Performance
Jeena Sikho Lifecare Limited share price chart: -13.91% return over the past month. 52-week high ₹849.50, 52-week low ₹415.00.
Jeena Sikho Lifecare Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹507.40 | ₹590.60 | ₹501.60 | ₹590.60 | 186.14L (Cr) | |
| ₹570.00 | ₹572.50 | ₹492.00 | ₹492.20 | 27.58L (Cr) | |
| ₹635.95 | ₹639.70 | ₹599.55 | ₹614.95 | 7.30L (Cr) | |
| ₹626.30 | ₹626.30 | ₹626.30 | ₹626.30 | 0.00 (Cr) | |
| ₹634.90 | ₹639.20 | ₹623.05 | ₹626.30 | 2.36L (Cr) | |
| ₹638.00 | ₹648.00 | ₹630.15 | ₹634.85 | 3.01L (Cr) | |
| ₹661.00 | ₹661.00 | ₹626.60 | ₹635.30 | 5.74L (Cr) | |
| ₹658.80 | ₹680.00 | ₹645.00 | ₹649.75 | 3.01L (Cr) | |
| ₹660.00 | ₹680.20 | ₹642.00 | ₹654.20 | 3.64L (Cr) | |
| ₹652.50 | ₹660.70 | ₹638.50 | ₹650.60 | 2.51L (Cr) |
Jeena Sikho Lifecare Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹570.00 | ₹590.60 | ₹492.00 | ₹590.60 | +3.61% | |
| ₹675.15 | ₹784.45 | ₹599.55 | ₹614.95 | -8.92% | |
| ₹566.10 | ₹696.00 | ₹554.00 | ₹674.90 | +19.22% | |
| ₹581.20 | ₹635.00 | ₹534.40 | ₹539.70 | -7.14% | |
| ₹664.95 | ₹809.00 | ₹606.00 | ₹608.65 | -8.47% | |
| ₹680.50 | ₹748.90 | ₹642.35 | ₹664.35 | -2.37% | |
| ₹709.95 | ₹760.00 | ₹661.25 | ₹680.65 | -4.13% | |
| ₹742.00 | ₹835.00 | ₹679.50 | ₹707.35 | -4.67% | |
| ₹807.95 | ₹839.00 | ₹717.15 | ₹742.00 | -8.16% | |
| ₹715.20 | ₹849.50 | ₹699.50 | ₹798.75 | +11.68% | |
| ₹556.00 | ₹748.00 | ₹510.30 | ₹708.15 | +27.37% | |
| ₹432.95 | ₹584.00 | ₹432.90 | ₹553.15 | +27.76% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Jeena Sikho Lifecare Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Jeena Sikho Lifecare Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JSLL across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (37.93%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (50.24%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (23.44%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (134.85%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (70.05%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (37.81% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (72.79% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (33.81x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (63.61%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 58.20x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Weak Earnings Growth (-35.51% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-21.82 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 6.74%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Jeena Sikho Lifecare Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Jeena Sikho Lifecare Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
60.8/100 | ₹590.60₹591 | ₹8959.46₹8959.46 | 58.20Average 58.2 Average | 37.93%Excellent 37.93% Excellent | 50.24%Excellent 50.24% Excellent | 0.30Excellent 0.3 Excellent | 72.79%Excellent 72.79% Excellent | 37.81%Excellent 37.81% Excellent | 0.15% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1789.90₹1790 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6533.00₹6533 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4317.90₹4318 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1379.30₹1379 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1274.00₹1274 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2249.80₹2250 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹1078.30₹1078 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2299.00₹2299 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1429.20₹1429 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5239.00₹5239 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Jeena Sikho Lifecare Limited PE Ratio History
Historical price-to-earnings ratio for JSLL — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹7.30 | ₹680.65 | 93.2x |
| FY 2024 | ₹5.57 | ₹2130.25 | 382.6x |
| FY 2023 | ₹2.74 | ₹591.00 | 215.9x |
| FY 2022 | ₹0.90 | ₹130.72 | 144.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Jeena Sikho Lifecare Limited Dividend History
Annual cash dividends paid by JSLL — dividend yield 0.15%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹10.38 Cr |
| FY 2024 | ₹2.76 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Jeena Sikho Lifecare Limited Quarterly Performance
Latest quarterly metrics for JSLL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
70.05%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
134.85%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
37.81%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
72.79%
Compounded annual net profit growth over 5 years
Jeena Sikho Lifecare Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for JSLL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Jeena Sikho Lifecare Limited Financial Statements
Annual income statement, balance sheet and cash flow for Jeena Sikho Lifecare Limited (JSLL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Jeena Sikho Lifecare Limited
About JSLL (Jeena Sikho Lifecare Limited)
Jeena Sikho Lifecare Limited is a dynamic and rapidly evolving pharmaceutical company rooted in the ancient wisdom of Ayurveda. The company is primarily engaged in the development,... manufacturing, and distribution of a diverse portfolio of Ayurvedic formulations designed to promote holistic wellness and address a wide range of health concerns. From meticulously crafted herbal remedies to specialized dietary supplements, Jeena Sikho Lifecare is dedicated to leveraging the power of natural ingredients, sourced responsibly and processed with stringent quality control measures, to create effective and accessible healthcare solutions. The organization seeks to bridge the gap between traditional Ayurvedic practices and modern pharmaceutical standards. Beyond its product line, Jeena Sikho Lifecare is committed to delivering comprehensive healthcare services that complement its Ayurvedic offerings. The company operates a network of specialized clinics and healthcare facilities where experienced practitioners provide personalized consultations and customized treatment plans. These services encompass a variety of therapeutic modalities, including Panchakarma, a detoxifying and rejuvenating Ayurvedic treatment, as well as expert guidance on diet, lifestyle, and preventative care. Through this integrated approach, Jeena Sikho Lifecare aims to empower individuals to take control of their health and well-being, fostering a deeper understanding of the interconnectedness of mind, body, and spirit. Jeena Sikho Lifecare Limited distinguishes itself through a commitment to research and innovation, constantly exploring new applications of Ayurvedic principles and integrating them with cutting-edge scientific advancements. By investing in research and development, the company strives to enhance the efficacy and safety of its formulations, while also expanding its range of offerings to meet the evolving needs of the healthcare market. The company's goal is to solidify its position as a trusted provider of authentic and evidence-based Ayurvedic solutions, contributing to the promotion of natural and sustainable healthcare practices.
Company Details
Key Leadership
Corporate Events
JSLL Share Price: Frequently Asked Questions
What is the current share price of Jeena Sikho Lifecare Limited?
Jeena Sikho Lifecare Limited (JSLL) trades at ₹590.60 on NSE and BSE. Market cap ₹8.96K (Cr). Educational data only.
What is the P/E ratio of Jeena Sikho Lifecare Limited?
Jeena Sikho Lifecare Limited has a P/E of 58.20x vs industry average 31.77x.
What is the Bull Run score for Jeena Sikho Lifecare Limited?
Jeena Sikho Lifecare Limited has a Bull Run score of 60.8/100 based on 25+ financial parameters.
Does Jeena Sikho Lifecare Limited pay dividends?
Jeena Sikho Lifecare Limited has a dividend yield of 0.15%. Past dividends don't guarantee future payments.
What is the ROE of Jeena Sikho Lifecare Limited?
Jeena Sikho Lifecare Limited has ROE of 37.93%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Jeena Sikho Lifecare Limited?
Jeena Sikho Lifecare Limited has debt-to-equity of 0.30.
Is Jeena Sikho Lifecare Limited a good investment?
Bull Run gives Jeena Sikho Lifecare Limited a score of 60.8/100. This is not investment advice — consult a SEBI-registered advisor.